Document is current
Any future updates will be listed below
-
Authors
Howard, Jordyn Ann
Kuznietsova, Halyna
Dziubenko, Natalia
Aigle, Axel
Natuzzi, Marco
Thomas, Eloise
Lysenko, Vladimir
David, Laurent
Brichart, Thomas
Lux, François
Tillement, Olivier
-
Funding
Funding for this research was provided by:
Horizon 2020 Framework Programme (101008159, 101008159, 101008159)
- License Information
-
More Information
Article History
Received: 29 November 2022
Accepted: 27 January 2023
First Online: 7 February 2023
Competing interests
: T. B., O. T, F. L., M. N. and L. D have to disclose the patent FR2007997 that protect Chitosan@DOTAGA. J. A. H., T. B., O. T., F. L. and L. D. have to disclose the patent EP22306238 that protect Chitosan@DOTAGA as an oral chelating agent for cadmium and lead. J. A. H., T. B., M. N. and A. A. are employees of MexBrain company. T. B., O. T. and F. L. possess shares in the company. Other authors have nothing to disclose.
